Analysis of a maternal health medicines pipeline database 2000-2021: New candidates for the prevention and treatment of fetal growth restriction.
Shao LimAnnie R A McDougallMaya GoldsteinAndrew TuttleRoxanne HastieStephen TongAnne AmmerdorfferSara RushwanChristina RicciAhmet Metin GülmezogluJoshua P VogelPublished in: BJOG : an international journal of obstetrics and gynaecology (2023)
Aspirin, L-arginine and vitamin D are promising, high potential preventative agents for fetal growth restriction. Based on the medicines pipeline, new pharmacological agents for fetal growth restriction are unlikely to emerge in the near future.
Keyphrases
- healthcare
- low dose
- public health
- nitric oxide
- current status
- emergency department
- type diabetes
- cardiovascular events
- cardiovascular disease
- combination therapy
- body mass index
- birth weight
- pregnancy outcomes
- acute coronary syndrome
- coronary artery disease
- pregnant women
- adverse drug
- amino acid
- percutaneous coronary intervention
- health promotion
- preterm birth